NVIDIA Soars 39% in 2025: Will the Stock Carry Momentum in 2026?

NVIDIA reported blockbuster fiscal Q3 2026 results driven by its Data Center segment, which generated $51.22 billion (89.8% of sales), up 66% year-over-year and 25% sequentially on strong Blackwell/Hopper GPU demand; overall revenues rose 62% YoY and non-GAAP EPS climbed 60%. The company provided upbeat guidance with Q4 revenue expected at $65 billion (+66% YoY) and a 75% gross margin (up 150 bps YoY), while free cash flow totaled $23.75 billion in the quarter ($66.53 billion YTD), cash balances reached $60.6 billion, and the firm returned $12.46 billion via buybacks in the quarter ($36.27 billion YTD) plus $243 million in dividends. NVDA's forward 12-month P/E of 26.8x trades below the industry average and the stock has outperformed peers year-to-date, supporting Zacks' Buy stance and making the company a high-conviction AI/capital-allocation play for investors.

Analysis

Market structure: NVDA is the clear winner as hyperscalers and enterprises front-load GPU capacity for LLM training/inference, increasing NVIDIA's pricing power and allowing gross margins to target ~75% (per guidance). Direct beneficiaries include cloud providers and ISVs that monetize LLMs; losers are cyclic/analog names (TXN) and legacy mobile suppliers (QCOM) who lack exposure to generative-AI acceleration. Supply/demand now tilts tight for high-end GPUs — demand growth likely >50% YoY for next 4–8 quarters, implying continued outsize revenue share for NVIDIA.

Risk assessment: Key tail risks are US/ally export controls to China, protracted TSMC capacity constraints, and a sharp pullback in hyperscaler capex (a >20% YoY spend cut would materially hit guidance). Immediate (days) risk: earnings-driven IV spikes and mean reversion; short-term (0–6 months): guidance misses or inventory destocking; long-term (1–3 years): customer verticals building custom silicon (20–30% share risk). Monitor gross margin inflection points — a drop below 70% would be a red flag.

Trade implications: Tactical: establish a core long NVDA allocation via 12–18 month LEAPS (buy Jan 2027 calls ~30% OTM) sized 2–3% NAV and hedge with 6–9 month puts 15–20% OTM if downside protection desired. Pair trade: long NVDA (2%) / short TXN (1.25%) to isolate AI exposure vs analog cyclical risk; target pair profit 20% relative, stop-loss if NVDA underperforms STM/QCOM by >10% in 30 days. Rotate 3–6% cash from broad semiconductor longs into AI infrastructure and datacenter capex names.

Contrarian angles: Consensus understates single-customer concentration (hyperscalers ≫50% DC rev) and supply-chain concentration (TSMC). The market may be underpricing regulatory fragmentation — if meaningful export bans return, NVDA multiple could compress from ~27x to <20x. Historical parallel: rapid adoption cycles (GPU in 2016–18) produced outsized returns then multi-quarter mean reversion; plan for similar 20–40% drawdowns on sentiment shocks and size positions accordingly.

Key Decisions for Investors

• Establish a 2–3% NAV long NVDA position via 12–18 month LEAPS (buy Jan 2027 calls ~30% OTM); add up to +1.5% on any pullback ≥10% within 3 months. Trim 50% of this position if NVDA trades up +25% from entry or if quarterly gross margin guidance falls below 70%.
• Implement a relative-value pair: long NVDA 2.0% NAV / short TXN 1.25% NAV to hedge market beta while capturing AI vs analog divergence; take profits on the pair after 20% relative outperformance and cut losses if NVDA underperforms TXN by >10% over 30 trading days.
• If seeking income with reduced directional risk, sell NVDA 3-month covered calls 10% OTM against existing NVDA stock (roll monthly) when implied vol > realized vol by ≥4 vol points; close or roll if shares are called away or IV spreads compress below 2 vol points.
• Reduce direct exposure to legacy analog/industrial semiconductors (e.g., TXN) by 2–4% of portfolio weight and redeploy into AI infra/ datacenter names or NVDA exposure over the next 30–90 days; monitor export-control news and TSMC capacity reports—if new export restrictions occur within 60 days, cut NVDA exposure by another 50%.